Emcure Pharmaceuticals Limited (NSE: EMCURE)

Market Cap	269.13B
Revenue (ttm)	72.56B
Net Income (ttm)	5.67B
Shares Out	189.43M
EPS (ttm)	31.02
PE Ratio	45.80
Forward PE	32.00
Dividend	n/a
Ex-Dividend Date	n/a

Volume	125,715
Open	1,387.25
Previous Close	1,387.25
Day's Range	1,382.55 - 1,435.00
52-Week Range	1,225.00 - 1,580.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 6, 2025

About Emcure Pharmaceuticals

Emcure Pharmaceuticals Limited engages in the developing, manufacturing, and marketing pharmaceutical products worldwide. It offers products in various therapeutic areas, such as gynecology, cardiovascular, anti-infectives, HIV antivirals, respiratory, gastrointestinal, pain and analgesics, blood related, oncology/anti-neoplastics, anti-diabetic, hormones, neurology/central nervous system, dermatology, and other areas, as well as vitamins, minerals, and nutrients. The company also develops products across various platforms, including chiral mol...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1981
• Employees: 10,852
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: EMCURE

Financial Performance

In 2023, Emcure Pharmaceuticals's revenue was 66.58 billion, an increase of 11.23% compared to the previous year's 59.86 billion. Earnings were 4.98 billion, a decrease of -6.36%.